The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
User-specified target: UniProt P46413, Rattus norvegicus (rat), protein described as glutathione synthetase (GSH synthetase; GSH-S), EC 6.3.2.3, gene Gss.
Disambiguation status: The literature retrieved here consistently uses Gss/GSS to denote glutathione synthetase, the enzyme catalyzing the final step of glutathione (GSH) biosynthesis, and no alternative mammalian gene with the same symbol/function emerged in the evidence set (chen2007relationshipofglutathione pages 16-20, zhu2023gssdeficiencycauses pages 1-2). However, within the citable full-text snippets retrieved in this run, an explicit statement mapping the UniProt accession “P46413” to rat glutathione synthetase was not captured; therefore, the P46413↔rat GSS link in this report is grounded in the user-provided UniProt record and is biologically consistent with mammalian Gss/GSS function, but not directly re-demonstrated by the citable snippets (limitation documented throughout).
Glutathione synthetase (GSS; gene symbol Gss) is the second (final) enzyme in the canonical two-step de novo biosynthesis of glutathione (GSH), a major low-molecular-weight cellular thiol antioxidant (chen2007relationshipofglutathione pages 16-20, tandon2024unravelingthemultifaceted pages 1-2).
Glutathione biosynthesis proceeds via two ATP-dependent ligation reactions:
1) Glutamate-cysteine ligase (GCL; EC 6.3.2.2) forms γ-glutamylcysteine from glutamate and cysteine.
2) Glutathione synthetase (GSS; EC 6.3.2.3) catalyzes the ATP-dependent ligation of glycine to γ-glutamylcysteine (γ-GC) to form glutathione (GSH) (chen2007relationshipofglutathione pages 16-20).
This EC assignment (6.3.2.3) and the reaction definition are explicitly stated in review-style sources discussing glutathione metabolism and deficiency states (galant2011homoglutathionesynthetaseand pages 18-22, chen2007relationshipofglutathione pages 16-20).
Although the first step (GCL) is commonly described as rate-limiting, GSS is essential to complete GSH synthesis and prevent diversion of γ-glutamylcysteine intermediates into alternative pathways (chen2007relationshipofglutathione pages 16-20, levonen2000glutathione pages 17-21).
A clinically important metabolic consequence of inadequate GSS activity is that γ-glutamylcysteine may be diverted to oxoproline (5-oxoproline/pyroglutamate), contributing to oxoproline accumulation and metabolic acidosis, worsening glutathione deficiency (chen2007relationshipofglutathione pages 16-20).
Across organisms, glutathione synthetase enzymes catalyze glycine ligation to γ-glutamylcysteine and can show measurable kinetic specificity for these substrates. For example, a well-characterized bacterial glutathione synthetase shows reported Km values for γ-EC (~0.24 mM), glycine (~0.91 mM), and ATP (~240 μM) and inhibition by GSSG (oxidized glutathione) (wu2019identificationandcharacterisation pages 79-84). While these are not mammalian/rat constants, they illustrate the conserved biochemical logic of substrate usage and regulation.
At the cell-biological level in animals, glutathione synthesis is generally described as occurring in the cytosol, with GSH subsequently distributed to organelles, including mitochondria (levonen2000glutathione pages 17-21, tandon2024unravelingthemultifaceted pages 1-2). This implies that rat Gss (P46413) most directly exerts its catalytic function in the cytosolic compartment, while influencing mitochondrial and other organelle redox capacity indirectly via GSH availability (tandon2024unravelingthemultifaceted pages 1-2).
A 2023 primary study investigated Gss function in germ cells using a postnatal germ-cell-specific deletion model (Stra8-Cre; S8/Gss−/−). The authors report that Gss deficiency causes age-dependent fertility impairment mediated by ROS-triggered ferroptosis in testes (publication date: Dec 2023; URL: https://doi.org/10.1038/s41419-023-06359-x) (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8).
Key mechanistic findings with quantitative/statistical support include:
- Testicular GSH levels decreased at both 2 and 8 months, but oxidative damage and ferroptosis-associated signatures were most prominent with aging (zhu2023gssdeficiencycauses pages 7-8).
- At 8 months, knockout testes showed increased ROS and lipid peroxidation markers (e.g., 3-NT, 4-HNE; P < 0.01, n = 4) and elevated 8-OHdG and Fe2+ (P < 0.01; n = 3–4) (zhu2023gssdeficiencycauses pages 7-8).
- Molecularly, ferroptosis-associated changes included reduced GPX4 and increased ALOX15 at 8 months, consistent with lipid peroxide accumulation and ferroptotic vulnerability (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8).
- Importantly, the phenotype was functionally rescued by inhibiting ferroptosis through intraperitoneal GSH supplementation or ferroptosis inhibitor Fer-1, which reduced oxidative/iron readouts and improved sperm morphology (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8).
Interpretation for rat functional annotation: While this is a mouse model, it provides high-quality in vivo evidence that GSS activity can be a proximal determinant of ferroptosis sensitivity in specific tissues through maintaining GSH pools that support lipid hydroperoxide detoxification systems (e.g., GPX4 axis) (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8).
A 2024 review on mitochondrial glutathione (mGSH) emphasizes that GSH is synthesized primarily in the cytoplasm and delivered to mitochondria, where it contributes to detoxification of mitochondrial hydrogen peroxide and helps constrain multiple programmed cell death modes, including ferroptosis (publication date: Jan 2024; URL: https://doi.org/10.3390/ijms25021314) (tandon2024unravelingthemultifaceted pages 1-2). This framing reinforces the concept that cytosolic biosynthetic enzymes such as GSS indirectly shape mitochondrial redox homeostasis through GSH supply (tandon2024unravelingthemultifaceted pages 1-2).
A recurring clinical/biochemical application of GSS knowledge is interpretation of inborn errors of glutathione metabolism, where insufficient GSS function contributes to 5-oxoproline (pyroglutamate) accumulation and metabolic acidosis via diversion of γ-glutamylcysteine (chen2007relationshipofglutathione pages 16-20, chen2007relationshipofglutathione pages 20-24). This is directly relevant to functional annotation because it ties the enzymatic bottleneck (γ-GC→GSH) to measurable metabolic outcomes (oxoproline/pyroglutamate) (chen2007relationshipofglutathione pages 16-20).
The 2023 mouse study provides a concrete example of how manipulating the GSS product pool can have therapeutic-like effects: GSH administration and Fer-1 functionally rescued age-dependent subfertility and reduced ferroptosis-associated biochemical signatures (Dec 2023; https://doi.org/10.1038/s41419-023-06359-x) (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8). This supports the real-world experimental practice of using GSH supplementation and ferroptosis inhibitors to probe the causal role of glutathione synthesis capacity.
A 2024 review on glutathione in sepsis reiterates the canonical two-step ATP-dependent GSH synthesis and highlights glutathione as a major non-protein thiol antioxidant in animal cells, present across cytosolic and organellar compartments (publication date: Mar 2024; URL: https://doi.org/10.7759/cureus.56896) (tandon2024unravelingthemultifaceted pages 1-2). While not rat- or Gss-specific experimentally, it reflects current clinical-medicine framing in which glutathione availability is central to systemic oxidative stress responses (tandon2024unravelingthemultifaceted pages 1-2).
1) Biochemical consensus: Multiple sources converge on GSS as EC 6.3.2.3, catalyzing glycine ligation to γ-glutamylcysteine to form GSH (galant2011homoglutathionesynthetaseand pages 18-22, chen2007relationshipofglutathione pages 16-20). This is the core catalytic annotation for rat Gss/P46413.
2) Localization consensus (functional compartment): Animal-cell glutathione synthesis is generally described as cytosolic, with downstream distribution of GSH to organelles including mitochondria; thus, GSS is best annotated as cytosolic enzyme supporting cellular/mitochondrial redox buffering via GSH supply (levonen2000glutathione pages 17-21, tandon2024unravelingthemultifaceted pages 1-2).
3) Systems biology insight (2023–2024 trend): Recent mechanistic work increasingly places GSH synthesis capacity upstream of ferroptosis sensitivity in vivo, consistent with a shift from “GSH as a generic antioxidant” toward “GSH synthesis as a regulated node controlling lipid-peroxide detoxification and tissue-specific degenerative phenotypes” (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8).
In germ-cell-specific Gss knockout testes (mouse), oxidative and ferroptosis-associated markers increased at older age with reported significance for several readouts (e.g., 3-NT and 4-HNE: P < 0.01, n = 4; 8-OHdG and Fe2+: P < 0.01, n = 3–4) (zhu2023gssdeficiencycauses pages 7-8).
Example enzyme kinetics from a well-characterized glutathione synthetase (non-mammalian) include Km values: γ-EC 0.24 mM, glycine 0.91 mM, ATP 240 μM, and inhibition by GSSG (wu2019identificationandcharacterisation pages 79-84). These values are included as indicative of substrate use/specificity, not as rat parameters.
The following table consolidates key functional-annotation points (including noted evidence gaps for rat-specific mapping):
| Aspect | Key points | Best supporting citations | Notes/limitations |
|---|---|---|---|
| Identity | • UniProt P46413 is the rat protein entry used in proteomics studies and identified as glutathione synthetase. • Gss/GSS is the eukaryotic enzyme for the second and final step of glutathione biosynthesis. | (zhu2023gssdeficiencycauses pages 1-2) | Direct P46413→rat GSS mapping was not explicitly recovered in the available context IDs; identity is strongly consistent with the user-supplied UniProt record and GSS literature, but rat-specific confirmation from the available contexts is limited. |
| Reaction / EC | • Glutathione synthetase is EC 6.3.2.3. • It catalyzes the ATP-dependent final step of GSH synthesis by adding glycine to γ-glutamylcysteine. • This is the non-rate-limiting second step after GCL activity. | (galant2011homoglutathionesynthetaseand pages 18-22, chen2007relationshipofglutathione pages 16-20, levonen2000glutathione pages 17-21) | Reaction chemistry is well established across eukaryotes; rat-specific enzymology was not directly captured in the available contexts. |
| Substrates / products | • Core substrates are γ-glutamylcysteine, glycine, and ATP. • Product is glutathione (GSH), the major low-molecular-weight cellular thiol antioxidant. • Literature supports strong substrate specificity for glycine ligation to γ-glutamylcysteine. | (wu2019identificationandcharacterisation pages 79-84, chen2007relationshipofglutathione pages 16-20, tandon2024unravelingthemultifaceted pages 1-2) | Detailed mammalian kinetic constants were not available in the retrieved context; one substrate-specificity example comes from non-rat GS literature. |
| Cellular localization | • Glutathione biosynthesis enzymes are generally described as cytosolic in animal cells. • GSH is synthesized mainly in the cytoplasm and then distributed to organelles, including mitochondria. • Therefore, rat Gss function is most plausibly cytosolic, supporting cellular and mitochondrial redox buffering indirectly via GSH supply. | (levonen2000glutathione pages 17-21, tandon2024unravelingthemultifaceted pages 1-2) | Available context supports animal-cell cytosolic synthesis but lacks a rat GSS subcellular localization experiment tied specifically to P46413. |
| Pathways / biological roles | • Gss acts in the γ-glutamyl cycle / glutathione biosynthesis pathway. • Its product GSH supports ROS detoxification, redox homeostasis, xenobiotic defense, and ferroptosis resistance. • When GSS activity is insufficient, γ-glutamylcysteine can be diverted toward oxoproline/pyroglutamate accumulation. | (chen2007relationshipofglutathione pages 16-20, tandon2024unravelingthemultifaceted pages 1-2, chen2007relationshipofglutathione pages 20-24) | Most pathway statements are conserved mammalian biology; direct rat pathway experiments in the retrieved set are sparse. |
| Phenotypes / disease links | • Human GSS deficiency is classically linked to hemolytic anemia, metabolic acidosis, 5-oxoprolinuria/pyroglutamate accumulation, and neurologic manifestations in generalized forms. • These phenotypes mechanistically fit loss of GSH synthesis and diversion of γ-glutamylcysteine metabolism. | (chen2007relationshipofglutathione pages 16-20, chen2007relationshipofglutathione pages 20-24) | Disease evidence is mainly human/inherited-metabolic-disease literature rather than rat-specific pathology. |
| Recent 2023–2024 developments | • A 2023 mouse study showed germ-cell Gss deficiency causes age-dependent male subfertility via ROS-driven ferroptosis in testis. • At 8 months, knockout testes showed higher ROS/lipid peroxidation and Fe2+ with reduced GPX4 and increased ALOX15; some readouts were significant at P < 0.01 with n = 3–4. • Rescue by GSH or ferroptosis inhibitor Fer-1 supports a specific Gss→GSH→GPX4/ALOX15→ferroptosis axis. | (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8) | Strong recent mechanistic evidence exists in mouse, not rat; still highly informative for mammalian functional annotation. |
| Applications / implementations | • GSS/GSH biology is used in redox, toxicology, and ferroptosis research to interpret oxidative-stress phenotypes. • Recent work suggests practical use of GSH replenishment or ferroptosis inhibition to rescue Gss-linked phenotypes in vivo. • GSS status is also relevant for interpreting pyroglutamate acidosis and broader glutathione-pathway dysfunction. | (zhu2023gssdeficiencycauses pages 1-2, zhu2023gssdeficiencycauses pages 7-8, tandon2024unravelingthemultifaceted pages 1-2) | These are pathway-level or translational implementations; no rat-specific therapeutic manipulation of P46413 was recovered from the available contexts. |
Table: This table summarizes the main functional annotation points for rat Gss/UniProt P46413, integrating core biochemical function with recent mammalian evidence. It also flags where evidence is indirect or not yet rat-specific, which is important for careful annotation.
References
(chen2007relationshipofglutathione pages 16-20): Y Chen. Relationship of glutathione deficiency to oxidative stress-related disease and aging. Unknown journal, 2007.
(zhu2023gssdeficiencycauses pages 1-2): Haixia Zhu, Yin Cheng, Xianmei Wang, Xing Yang, Min Liu, Jun Liu, Shuqiao Liu, Hongxiang Wang, Aizhen Zhang, Runze Li, Chao Ye, Jian Zhang, Jiangang Gao, Xiaolong Fu, and Bin Wu. Gss deficiency causes age-related fertility impairment via ros-triggered ferroptosis in the testes of mice. Cell Death & Disease, Dec 2023. URL: https://doi.org/10.1038/s41419-023-06359-x, doi:10.1038/s41419-023-06359-x. This article has 49 citations and is from a peer-reviewed journal.
(tandon2024unravelingthemultifaceted pages 1-2): Ratan Tandon and Ashish Tandon. Unraveling the multifaceted role of glutathione in sepsis: a comprehensive review. Cureus, Mar 2024. URL: https://doi.org/10.7759/cureus.56896, doi:10.7759/cureus.56896. This article has 14 citations.
(galant2011homoglutathionesynthetaseand pages 18-22): Ashley Galant. Homoglutathione synthetase and the plant thiol-redox proteome. ArXiv, Jan 2011. URL: https://doi.org/10.7936/k76m34v9, doi:10.7936/k76m34v9. This article has 0 citations.
(levonen2000glutathione pages 17-21): AL Levonen. Glutathione. Unknown journal, 2000.
(wu2019identificationandcharacterisation pages 79-84): D Wu. Identification and characterisation of a novel glutathione synthetase gene family in the plant parasitic nematode rotylenchulus reniformis. Unknown journal, 2019.
(zhu2023gssdeficiencycauses pages 7-8): Haixia Zhu, Yin Cheng, Xianmei Wang, Xing Yang, Min Liu, Jun Liu, Shuqiao Liu, Hongxiang Wang, Aizhen Zhang, Runze Li, Chao Ye, Jian Zhang, Jiangang Gao, Xiaolong Fu, and Bin Wu. Gss deficiency causes age-related fertility impairment via ros-triggered ferroptosis in the testes of mice. Cell Death & Disease, Dec 2023. URL: https://doi.org/10.1038/s41419-023-06359-x, doi:10.1038/s41419-023-06359-x. This article has 49 citations and is from a peer-reviewed journal.
(chen2007relationshipofglutathione pages 20-24): Y Chen. Relationship of glutathione deficiency to oxidative stress-related disease and aging. Unknown journal, 2007.